R&D Experimental Services: Discovery and Preclinical Research
Outsourcing your R&D project with Labtoo
The life cycle of drug development is extremely long and tedious: it has to undergo many complex and regulated phases in order to ensure its safety, efficacy, and quality for the patients. Pharmaceutical and biotech companies are facing increasing challenges and must identify solutions to respond to these new problems.
Lately, biotechnology companies tend to outsource their R&D projects and thus have included the use of service providers in their financial models for several reasons. On one hand, biotech companies have often limited financial resources as well as they do not have systematically the technological resources to perform all their projects in-house. Time is also a critical issue in the survival of a small company. Relaying steps of your studies to a specialized R&D services provider able to rapidly achieve a project could be therefore a wise choice.
This is why Labtoo developed a unique solution to support Labs, Biotechs, Medtechs, and Pharmaceutical companies in their R&D outsourcing management
Our Experimental Services for Research and Development in Biotechnologies
We are specialized in tailor-made projects for the pharmaceutical and biotech industry.
Select your options and start building your project.
What is included in our services?
Our team will handle your R&D service management from the beginning to the end
Perform a feasibility study by looking for existing expertise available within the network of partners
Set up a study protocole, financial quotation and preparing contracts with lab partners
Implement the study plan into a schedule, collect all needed materials and reagents and execute the service
Do you need more information about our experimental services?
How are the service providers selected?
Selecting the right structure type
When looking for a CRO, there are several choices: generalist or specialized CRO, small or large structure, well-known or not... While a large CRO recognized internationally instills confidence and allows more flexibility, small and medium-sized CROs in France or Europe offer a tailor-made and highly specialized service (cancerology, neurology, cardiology, etc.) that may be more relevant to your project. Moreover, size and quality are not always correlated.
Defining a budget
Even if a low price is an important criterion, it should not be the major one. If a services provider seems more relevant and more competent, although more expensive, it may be worthwhile to concede to a more substantial investment, which may protect further from additional costs (due to deadlines issues, or even a change of services provider during the study).
Rely on trust... or on a previous experience!
Delays in the preclinical phases can be extremely damaging to small structures and may even jeopardize their survival. Therefore, all R&D providers must be considered trustworthy partners. When presenting the project, he must be critical of the provided elements and challenge the protocol that you are submitting to him. Good advice will save time and thus money, and a realistic time frame and a presentation of the risks involved are must-haves. And of course, getting insights from a preliminary experience is likely to help to choose.
Experience, certifications, and regulatory compliance
Disease areas for experimental models
We are specialized in tailor-made projects for the pharmaceutical industry.
Select your options and start building your project.
